Get started
Author

Sanjay Bajpai

The Association Between Adherence to Insulin Therapy and Health Care Costs for Adults with Type 2 Diabetes: Evidence from a U.S. Retrospective Claims Database
2020 · Elizabeth L. Eby, Sanjay Bajpai, et al. · Journal of Managed Care & Specialty Pharmacy · 16
PDF
Perceptions About Glucagon Delivery Devices for Severe Hypoglycemia: Qualitative Research With Patients, Caregivers, and Acquaintances
2019 · Sanjay K. Bajpai, M. Janelle Cambron-Mellott, et al. · Clinical Therapeutics · 16
Nasal Glucagon Versus Injectable Glucagon for Severe Hypoglycemia: A Cost-Offset and Budget Impact Analysis
2019 · Johannes Pöhlmann, Beth D. Mitchell, et al. · Journal of Diabetes Science and Technology · 15
PDF
Health care resource utilization and cost of severe hypoglycemia treatment in insulin-treated patients with diabetes in the United States
2021 · Sanjay Bajpai, Siew Wong-Jacobson, et al. · Journal of Managed Care & Specialty Pharmacy · 14
PDF
Conversations and Reactions Around Severe Hypoglycemia (CRASH) Study: Results From People With Diabetes and Caregivers in the United States
2022 · Frank J. Snoek, Erik Spaepen, et al. · Clinical Diabetes · 11
PDF
Nasal Glucagon Is Easier to Use and More Preferred and Needs Less Effort to Administer Than Injectable Glucagon: User Perceptions of Glucagon Administration During Severe Hypoglycemia Simulation
2022 · Julie Settles, Deborah Hinnen, et al. · Endocrine Practice · 6
PDF
285-OR: Conversations and Reactions around Severe Hypoglycemia (CRASH): U.S. Results from a Global Survey of People with T1DM or Insulin-Treated T2DM and Caregivers
2019 · FRANK J. SNOEK, ALINA JILETCOVICI, et al. · Diabetes · 4
13-LB: Nasal vs. Injected Glucagon: User Experience Results of a Simulated Severe Hypoglycemia Study
2019 · JULIE SETTLES, CHRISTOPHER J. CHILD, et al. · Diabetes · 3
Nasal Glucagon Budget-Impact Model Shows Reduced Health Care Payer Costs for Severe Hypoglycemia Due to Emergency Services Costs Savings
2018 · BETH MITCHELL, JOHANNES POEHLMANN, et al. · Diabetes · 2
Formulary decisions without comparative effectiveness research.
2014 · Partha Anbil, Sanjay Bajpai · PubMed · 2
Development of a Measure to Assess Attitudes Towards Nasal versus Autoinjector Glucagon Delivery Devices for Treatment of Severe Hypoglycemia
2022 · Sanjay K Bajpai, M Janelle Cambron-Mellott, et al. · Diabetes Metabolic Syndrome and Obesity · 1
PDF
129-LB: Evaluation of Attitudes towards Two Glucagon Delivery Devices for Rescue Treatment of Severe Hypoglycemia
2020 · SANJAY K. BAJPAI, JANELLE CAMBRON-MELLOTT, et al. · Diabetes · 1
Advancements in the role of RPD3-type histone deacetylases in plant development and stress responses
2026 · Sanjay Kumar Bajpai, Nisha, et al. · Physiology and Molecular Biology of Plants
Conversations and Reactions Around Severe Hypoglycemia (CRASH) Study: Results From People With Diabetes and Caregivers in the United States
2022 · Frank J. Snoek, Erik Spaepen, et al.
Conversations and Reactions Around Severe Hypoglycemia (CRASH) Study: Results From People With Diabetes and Caregivers in the United States
2022 · Frank J. Snoek, Erik Spaepen, et al.
90-LB: Treatments and Trends in Glycemic Control for Patients with Type 2 Diabetes Mellitus Treatment following Metformin
2019 · SANJAY K. BAJPAI, RADHIKA NAIR, et al. · Diabetes
444-P: Evaluating Factors Associated with Cardiovascular and Cerebrovascular Complications of Type 2 Diabetes
2019 · TODD G. PREWITT, DAVID MANNER, et al. · Diabetes
Formulary decision making in health maintenance organizations involving non-steroidal anti-inflammatory drugs /
1992 · Sanjay Bajpai · OhioLink ETD Center (Ohio Library and Information Network)
PDF
Works count: 22
Citation count: 91
H-index: 6
I10-index: 5
Year
Topic
Type